1 January 2024 true No description of principal activity Taxfiler 2024.6 07730468business:PrivateLimitedCompanyLtd2024-01-012024-12-31 077304682023-12-31 07730468business:EntityNoLongerTradingButTradedInPast2024-01-012024-12-31 077304682024-01-012024-12-31 07730468business:AuditExempt-NoAccountantsReport2024-01-012024-12-31 07730468business:FilletedAccounts2024-01-012024-12-31 077304682024-12-31 07730468business:Director12024-01-012024-12-31 07730468business:RegisteredOffice2024-01-012024-12-31 077304682023-12-31 07730468core:WithinOneYear2024-12-31 07730468core:WithinOneYear2023-12-31 07730468core:ShareCapitalcore:PreviouslyStatedAmount2024-12-31 07730468core:ShareCapitalcore:PreviouslyStatedAmount2023-12-31 07730468core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-12-31 07730468core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-12-31 07730468core:PreviouslyStatedAmount2024-12-31 07730468core:PreviouslyStatedAmount2023-12-31 07730468business:SmallEntities2024-01-012024-12-31 07730468countries:EnglandWales2024-01-012024-12-31 07730468core:ComputerEquipment2024-01-012024-12-31 07730468core:ComputerEquipment2023-12-31 07730468core:ComputerEquipment2024-12-31 077304682023-01-012023-12-31 iso4217:GBP xbrli:pure
Company Registration No. 07730468 (England and Wales)
VITANE PHARMA LIMITED Unaudited accounts for the year ended 31 December 2024
VITANE PHARMA LIMITED Unaudited accounts Contents
Page
- 2 -
VITANE PHARMA LIMITED Company Information for the year ended 31 December 2024
Director
MOHAMMED, Fahad Hussain
Company Number
07730468 (England and Wales)
Registered Office
20 WENLOCK ROAD LONDON N1 7GU ENGLAND
Accountants
Taxez 5 South Charlotte Street Edinburgh EH2 4AN
- 3 -
VITANE PHARMA LIMITED Statement of financial position as at 31 December 2024
2024 
2023 
Notes
£ 
£ 
Current assets
Cash at bank and in hand
1,085 
1,746 
Creditors: amounts falling due within one year
(20,286)
(20,136)
Net current liabilities
(19,201)
(18,390)
Net liabilities
(19,201)
(18,390)
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
(19,301)
(18,490)
Shareholders' funds
(19,201)
(18,390)
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 10 April 2025 and were signed on its behalf by
MOHAMMED, Fahad Hussain Director Company Registration No. 07730468
- 4 -
VITANE PHARMA LIMITED Notes to the Accounts for the year ended 31 December 2024
1
Statutory information
VITANE PHARMA LIMITED is a private company, limited by shares, registered in England and Wales, registration number 07730468. The registered office is 20 WENLOCK ROAD, LONDON, N1 7GU, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
33% Straight line
4
Tangible fixed assets
Computer equipment 
£ 
Cost or valuation
At cost 
At 1 January 2024
999 
At 31 December 2024
999 
Depreciation
At 1 January 2024
999 
At 31 December 2024
999 
Net book value
At 31 December 2024
- 
5
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Taxes and social security
- 
(217)
Loans from directors
20,047 
20,294 
Accruals
239 
59 
20,286 
20,136 
- 5 -
VITANE PHARMA LIMITED Notes to the Accounts for the year ended 31 December 2024
6
Average number of employees
During the year the average number of employees was 1 (2023: 1).
- 6 -